Our Services
Spravato® Therapy
SPRAVATO® is the first FDA-approved nasal spray medication, taken with an oral antidepressant, for Adults with treatment-resistant depression (TRD) Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions.
Intensive Outpatient Program
Our Intensive Outpatient Program is designed for patients with significant stress, anxiety, or depression whose needs cannot be met by traditional outpatient psychotherapy and medication management. It is not intended for patients who require inpatient hospital treatment.
Medication Management
Medication management services are tailored to each patient’s unique mental health needs. Our experienced psychiatric providers conduct comprehensive evaluations, monitor treatment effectiveness, and make ongoing adjustments to ensure optimal outcomes.
Alumni Group
Recovery is a journey, and we believe that connection, support, and personal growth continue long after treatment ends. Our Alumni Group is a welcoming community for former patients who wish to stay connected, celebrate milestones, share experiences, and encourage one another in maintaining emotional wellness and personal success.
Treatment Resistant Depression
We offer various modalities of treatment can be useful for patients experiencing Treatment Resistant Depression including Transcranial Magnetic Stimulation, SPRAVATO®/esketamine intranasal spray, and, Electroconvulsive Therapy. All of these FDA approved methods for TRD require a consultation with one of our qualified providers to appropriately determine efficacy.
Areas of Clinical Expertise
|
|
|